Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Na ïve, Compensated Cirrhotic HCV Patients

ConclusionEarly real-world evidence indicates high effectiveness of the 8-week G/P regimen in TN/CC patients of HCV genotypes 1 –6 from a large US claims database.

Source: Infectious Diseases and Therapy - June 17, 2023 Category: Infectious Diseases Source Type: research